Header Logo

Connection

MARIA REDONDO to Diabetes Mellitus, Type 1

Back to Details
This is a "connection" page, showing publications MARIA REDONDO has written about Diabetes Mellitus, Type 1.
MARIA REDONDO
Connection Strength
24.618
Diabetes Mellitus, Type 1
  1. Genetic Associations With C-peptide Levels Before Type 1 Diabetes Diagnosis in At-risk Relatives. J Clin Endocrinol Metab. 2025 Mar 17; 110(4):e1046-e1050.
    View in: PubMed
    Score: 0.537
  2. Type 1 Diabetes Genetic Risk Scores: History, Application and Future Directions. Curr Diab Rep. 2025 Feb 08; 25(1):22.
    View in: PubMed
    Score: 0.533
  3. Characteristics of autoantibody-positive individuals without high-risk HLA-DR4-DQ8 or HLA-DR3-DQ2 haplotypes. Diabetologia. 2025 Mar; 68(3):588-601.
    View in: PubMed
    Score: 0.527
  4. Age and sex mark clinical differences in the presentation of pediatric type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2025 Jan 29; 38(1):22-28.
    View in: PubMed
    Score: 0.526
  5. Reply to 'Slowly progressive insulin dependent diabetes mellitus in type 1 diabetes endotype 2'. Nat Rev Endocrinol. 2024 May; 20(5):313.
    View in: PubMed
    Score: 0.505
  6. Inaccurate diagnosis of diabetes type in youth: prevalence, characteristics, and implications. Sci Rep. 2024 04 17; 14(1):8876.
    View in: PubMed
    Score: 0.504
  7. Elevated Serum IgA at Onset of Type 1 Diabetes in Children. Pediatr Diabetes. 2024; 2024:7284088.
    View in: PubMed
    Score: 0.501
  8. Diabetes Study of Children of Diverse Ethnicity and Race: Study design. Diabetes Metab Res Rev. 2024 Mar; 40(3):e3744.
    View in: PubMed
    Score: 0.487
  9. Baseline leptin predicts response to metformin in adolescents with type 1 diabetes and increased body mass index. Diabetes Obes Metab. 2023 11; 25(11):3420-3423.
    View in: PubMed
    Score: 0.479
  10. Heterogeneity and endotypes in type 1 diabetes mellitus. Nat Rev Endocrinol. 2023 09; 19(9):542-554.
    View in: PubMed
    Score: 0.475
  11. Age Ain't Nothing But a Number . . . or Is It? Diabetes Care. 2023 06 01; 46(6):1135-1136.
    View in: PubMed
    Score: 0.474
  12. Phenotypes Associated With Zones Defined by Area Under the Curve Glucose and C-peptide in a Population With Islet Autoantibodies. Diabetes Care. 2023 05 01; 46(5):1098-1105.
    View in: PubMed
    Score: 0.471
  13. Milder loss of insulin-containing islets in individuals with type 1 diabetes and type 2 diabetes-associated TCF7L2 genetic variants. Diabetologia. 2023 01; 66(1):127-131.
    View in: PubMed
    Score: 0.455
  14. On the road to universal screening for risk of type 1 diabetes. Lancet Diabetes Endocrinol. 2022 08; 10(8):554-555.
    View in: PubMed
    Score: 0.445
  15. Type 1 diabetes in diverse ancestries and the use of genetic risk scores. Lancet Diabetes Endocrinol. 2022 08; 10(8):597-608.
    View in: PubMed
    Score: 0.443
  16. Spectrum of Phenotypes and Causes of Type 2 Diabetes in Children. Annu Rev Med. 2022 01 27; 73:501-515.
    View in: PubMed
    Score: 0.432
  17. TCF7L2 Genetic Variants Do Not Influence Insulin Sensitivity or Secretion Indices in Autoantibody-Positive Individuals at Risk for Type 1 Diabetes. Diabetes Care. 2021 09; 44(9):2039-2044.
    View in: PubMed
    Score: 0.417
  18. Islet autoantibody types mark differential clinical characteristics at diagnosis of pediatric type 1 diabetes. Pediatr Diabetes. 2021 09; 22(6):882-888.
    View in: PubMed
    Score: 0.412
  19. Index60 as an additional diagnostic criterion for type 1 diabetes. Diabetologia. 2021 04; 64(4):836-844.
    View in: PubMed
    Score: 0.403
  20. The Evolution of Hemoglobin A1c Targets for Youth With Type 1 Diabetes: Rationale and Supporting Evidence. Diabetes Care. 2021 02; 44(2):301-312.
    View in: PubMed
    Score: 0.402
  21. Sex differences in circulating leptin as a marker of adiposity in obese or overweight adolescents with type 1 diabetes. BMJ Open Diabetes Res Care. 2020 10; 8(1).
    View in: PubMed
    Score: 0.394
  22. The clinical consequences of heterogeneity within and between different diabetes types. Diabetologia. 2020 10; 63(10):2040-2048.
    View in: PubMed
    Score: 0.392
  23. GLP-1 Receptor Agonist as Adjuvant Therapy in Type 1 Diabetes: No Apparent Benefit for Beta-Cell Function or Glycemia. J Clin Endocrinol Metab. 2020 08 01; 105(8).
    View in: PubMed
    Score: 0.389
  24. Decline Pattern of Beta Cell Function in LADA: Relationship to GAD Autoantibodies. J Clin Endocrinol Metab. 2020 08 01; 105(8).
    View in: PubMed
    Score: 0.389
  25. Challenges in the diagnosis of diabetes type in pediatrics. Pediatr Diabetes. 2020 11; 21(7):1064-1073.
    View in: PubMed
    Score: 0.389
  26. Single Islet Autoantibody at Diagnosis of Clinical Type 1 Diabetes is Associated With Older Age and Insulin Resistance. J Clin Endocrinol Metab. 2020 05 01; 105(5).
    View in: PubMed
    Score: 0.383
  27. Genetics of Type 1 Diabetes Comes of Age. Diabetes Care. 2020 01; 43(1):16-18.
    View in: PubMed
    Score: 0.374
  28. New insights on the genetics of type 1 diabetes. Curr Opin Endocrinol Diabetes Obes. 2019 08; 26(4):181-187.
    View in: PubMed
    Score: 0.363
  29. The Influence of Type 2 Diabetes-Associated Factors on Type 1 Diabetes. Diabetes Care. 2019 08; 42(8):1357-1364.
    View in: PubMed
    Score: 0.359
  30. Transcription Factor 7-Like 2 (TCF7L2) Gene Polymorphism and Progression From Single to Multiple Autoantibody Positivity in Individuals at Risk for Type 1 Diabetes. Diabetes Care. 2018 12; 41(12):2480-2486.
    View in: PubMed
    Score: 0.343
  31. A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk. Diabetes Care. 2018 09; 41(9):1887-1894.
    View in: PubMed
    Score: 0.338
  32. Response to Comment on Redondo et al. Racial/Ethnic Minority Youth With Recent-Onset Type 1 Diabetes Have Poor Prognostic Factors. Diabetes Care 2018;41:1017-1024. Diabetes Care. 2018 07; 41(7):e125-e126.
    View in: PubMed
    Score: 0.337
  33. Racial/Ethnic Minority Youth With Recent-Onset Type 1 Diabetes Have Poor Prognostic Factors. Diabetes Care. 2018 05; 41(5):1017-1024.
    View in: PubMed
    Score: 0.329
  34. Heterogeneity of Type 1 Diabetes: The Effect of Ethnicity. Curr Diabetes Rev. 2018; 14(3):266-272.
    View in: PubMed
    Score: 0.326
  35. Genetics of type 1 diabetes. Pediatr Diabetes. 2018 05; 19(3):346-353.
    View in: PubMed
    Score: 0.322
  36. Genetic Risk Scores for Type 1 Diabetes Prediction and Diagnosis. Curr Diab Rep. 2017 Oct 28; 17(12):129.
    View in: PubMed
    Score: 0.322
  37. TCF7L2 Genetic Variants Contribute to Phenotypic Heterogeneity of Type 1 Diabetes. Diabetes Care. 2018 02; 41(2):311-317.
    View in: PubMed
    Score: 0.321
  38. Racial and ethnic differences among children with new-onset autoimmune Type 1 diabetes. Diabet Med. 2017 10; 34(10):1435-1439.
    View in: PubMed
    Score: 0.315
  39. Diabetes care provider perceptions on family challenges of pediatric type 1 diabetes. Diabetes Res Clin Pract. 2017 Jul; 129:203-205.
    View in: PubMed
    Score: 0.312
  40. Serum undercarboxylated osteocalcin correlates with hemoglobin A1c in children with recently diagnosed pediatric diabetes. Pediatr Diabetes. 2017 Dec; 18(8):869-873.
    View in: PubMed
    Score: 0.305
  41. Dissecting heterogeneity in paediatric Type 1 diabetes: association of TCF7L2 rs7903146 TT and low-risk human leukocyte antigen (HLA) genotypes. Diabet Med. 2017 02; 34(2):286-290.
    View in: PubMed
    Score: 0.289
  42. Psychosocial aspects of type 1 diabetes in Latino- and Asian-American youth. Pediatr Res. 2016 09; 80(3):347-55.
    View in: PubMed
    Score: 0.289
  43. DPD epitope-specific glutamic acid decarboxylase (GAD)65 autoantibodies in children with Type 1 diabetes. Diabet Med. 2017 05; 34(5):641-646.
    View in: PubMed
    Score: 0.286
  44. Prevalence of cardiovascular risk factors in youth with type 1 diabetes and elevated body mass index. Acta Diabetol. 2016 Apr; 53(2):271-7.
    View in: PubMed
    Score: 0.273
  45. Serum adiposity-induced biomarkers in obese and lean children with recently diagnosed autoimmune type 1 diabetes. Pediatr Diabetes. 2014 Dec; 15(8):543-9.
    View in: PubMed
    Score: 0.255
  46. Pediatric Diabetes Consortium Type 1 Diabetes New Onset (NeOn) Study: factors associated with HbA1c levels one year after diagnosis. Pediatr Diabetes. 2014 Jun; 15(4):294-302.
    View in: PubMed
    Score: 0.239
  47. Types of pediatric diabetes mellitus defined by anti-islet autoimmunity and random C-peptide at diagnosis. Pediatr Diabetes. 2013 Aug; 14(5):333-40.
    View in: PubMed
    Score: 0.233
  48. LADA: time for a new definition. Diabetes. 2013 Feb; 62(2):339-40.
    View in: PubMed
    Score: 0.232
  49. Beta cell function and BMI in ethnically diverse children with newly diagnosed autoimmune type 1 diabetes. Pediatr Diabetes. 2012 Nov; 13(7):564-71.
    View in: PubMed
    Score: 0.221
  50. Therapeutics in pediatric diabetes: insulin and non-insulin approaches. Part of a series on Pediatric Pharmacology, guest edited by Gianvincenzo Zuccotti, Emilio Clementi, and Massimo Molteni. Pharmacol Res. 2012 Jan; 65(1):1-4.
    View in: PubMed
    Score: 0.210
  51. Concordance for islet autoimmunity among monozygotic twins. N Engl J Med. 2008 Dec 25; 359(26):2849-50.
    View in: PubMed
    Score: 0.174
  52. Specific human leukocyte antigen DQ influence on expression of antiislet autoantibodies and progression to type 1 diabetes. J Clin Endocrinol Metab. 2006 May; 91(5):1705-13.
    View in: PubMed
    Score: 0.143
  53. IA-2A positivity increases risk of progression within and across established stages of type 1 diabetes. Diabetologia. 2025 May; 68(5):993-1004.
    View in: PubMed
    Score: 0.134
  54. A Glucose Fraction Independent of Insulin Secretion: Implications for Type 1 Diabetes Progression in Autoantibody-Positive Cohorts. Diabetes Technol Ther. 2025 Mar; 27(3):179-186.
    View in: PubMed
    Score: 0.132
  55. Metabolic, genetic and immunological features of relatives of type 1 diabetes patients with elevated insulin resistance. J Endocrinol Invest. 2025 Mar; 48(3):765-775.
    View in: PubMed
    Score: 0.132
  56. Identification of atypical pediatric diabetes mellitus cases using electronic medical records. BMJ Open Diabetes Res Care. 2024 Nov 07; 12(6).
    View in: PubMed
    Score: 0.131
  57. Expression of beta-cell autoimmunity does not differ between potential dizygotic twins and siblings of patients with type 1 diabetes. J Autoimmun. 2004 Nov; 23(3):275-9.
    View in: PubMed
    Score: 0.131
  58. Random C-Peptide and Islet Antibodies at Onset Predict ? Cell Function Trajectory and Insulin Dependence in Pediatric Diabetes. Endocr Pract. 2024 Dec; 30(12):1149-1157.
    View in: PubMed
    Score: 0.130
  59. Effect of Oral Insulin on Early Combined Glucose and C-Peptide Endpoints in Individuals at High-Risk for Type 1 Diabetes. Pediatr Diabetes. 2024; 2024:8343868.
    View in: PubMed
    Score: 0.130
  60. Identification of type 1 diabetes risk phenotypes using an outcome-guided clustering analysis. Diabetologia. 2024 Nov; 67(11):2507-2517.
    View in: PubMed
    Score: 0.129
  61. Diabetic ketoacidosis in youth with diabetes mellitus during the COVID-19 pandemic. J Pediatr Endocrinol Metab. 2024 Sep 25; 37(9):759-763.
    View in: PubMed
    Score: 0.128
  62. Comparisons of Metabolic Measures to Predict T1D vs Detect a Preventive Treatment Effect in High-Risk Individuals. J Clin Endocrinol Metab. 2024 Jul 12; 109(8):2116-2123.
    View in: PubMed
    Score: 0.128
  63. Early Metabolic Endpoints Identify Persistent Treatment Efficacy in Recent-Onset Type 1 Diabetes Immunotherapy Trials. Diabetes Care. 2024 Jun 01; 47(6):1048-1055.
    View in: PubMed
    Score: 0.127
  64. Social Determinant of Health Impact on Diabetes Device Use and Clinical Outcomes in Youth with Type 1 Diabetes. Pediatr Diabetes. 2023; 2023:4751595.
    View in: PubMed
    Score: 0.122
  65. Plasma amino acid signatures define types of pediatric diabetes. Clin Nutr ESPEN. 2023 10; 57:21-28.
    View in: PubMed
    Score: 0.119
  66. Data Mining Framework for Discovering and Clustering Phenotypes of Atypical Diabetes. J Clin Endocrinol Metab. 2023 03 10; 108(4):834-846.
    View in: PubMed
    Score: 0.117
  67. Persistence of ?-Cell Responsiveness for Over Two Years in Autoantibody-Positive Children With Marked Metabolic Impairment at Screening. Diabetes Care. 2022 12 01; 45(12):2982-2990.
    View in: PubMed
    Score: 0.114
  68. The Transition From a Compensatory Increase to a Decrease in C-peptide During the Progression to Type 1 Diabetes and Its Relation to Risk. Diabetes Care. 2022 10 01; 45(10):2264-2270.
    View in: PubMed
    Score: 0.113
  69. Diabetic ketoacidosis at diabetes onset: still an all too common threat in youth. J Pediatr. 2013 Feb; 162(2):330-4.e1.
    View in: PubMed
    Score: 0.112
  70. Genetic control of autoimmunity in Type I diabetes and associated disorders. Diabetologia. 2002 May; 45(5):605-22.
    View in: PubMed
    Score: 0.110
  71. Utility of Diabetes Type-Specific Genetic Risk Scores for the Classification of Diabetes Type Among Multiethnic Youth. Diabetes Care. 2022 05 01; 45(5):1124-1131.
    View in: PubMed
    Score: 0.110
  72. Contrast Pattern Mining With the T1D Exchange Clinic Registry Reveals Complex Phenotypic Factors and Comorbidity Patterns Associated With Familial Versus Sporadic Type 1 Diabetes. Diabetes Care. 2022 03 01; 45(3):e56-e59.
    View in: PubMed
    Score: 0.109
  73. Index60 Identifies Individuals at Appreciable Risk for Stage 3 Among an Autoantibody-Positive Population With Normal 2-Hour Glucose Levels: Implications for Current Staging Criteria of Type 1 Diabetes. Diabetes Care. 2022 02 01; 45(2):311-318.
    View in: PubMed
    Score: 0.108
  74. The pathogenesis, natural history, and treatment of type 1 diabetes: time (thankfully) does not stand still. Lancet Diabetes Endocrinol. 2022 02; 10(2):90-92.
    View in: PubMed
    Score: 0.107
  75. Time to Peak Glucose and Peak C-Peptide During the Progression to Type 1 Diabetes in the Diabetes Prevention Trial and TrialNet Cohorts. Diabetes Care. 2021 10; 44(10):2329-2336.
    View in: PubMed
    Score: 0.104
  76. Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States. Diabetologia. 2001 Mar; 44(3):354-62.
    View in: PubMed
    Score: 0.101
  77. Genetics of type 1A diabetes. Recent Prog Horm Res. 2001; 56:69-89.
    View in: PubMed
    Score: 0.100
  78. The Effect of Ethnicity in the Rate of Beta-Cell Functional Loss in the First 3 Years After Type 1 Diabetes Diagnosis. J Clin Endocrinol Metab. 2020 12 01; 105(12).
    View in: PubMed
    Score: 0.100
  79. DR- and DQ-associated protection from type 1A diabetes: comparison of DRB1*1401 and DQA1*0102-DQB1*0602*. J Clin Endocrinol Metab. 2000 Oct; 85(10):3793-7.
    View in: PubMed
    Score: 0.098
  80. Racial-Ethnic Inequity in Young Adults With Type 1 Diabetes. J Clin Endocrinol Metab. 2020 08 01; 105(8).
    View in: PubMed
    Score: 0.097
  81. Early and late C-peptide responses during oral glucose tolerance testing are oppositely predictive of type 1 diabetes in autoantibody-positive individuals. Diabetes Obes Metab. 2020 06; 22(6):997-1000.
    View in: PubMed
    Score: 0.095
  82. Excess BMI Accelerates Islet Autoimmunity in Older Children and Adolescents. Diabetes Care. 2020 03; 43(3):580-587.
    View in: PubMed
    Score: 0.094
  83. Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes. Diabetes Care. 2020 01; 43(1):5-12.
    View in: PubMed
    Score: 0.093
  84. Heterophile anti-mouse immunoglobulin antibodies may interfere with cytokine measurements in patients with HLA alleles protective for type 1A diabetes. Diabetes. 1999 Nov; 48(11):2166-70.
    View in: PubMed
    Score: 0.092
  85. Using Relational Agents to Promote Family Communication Around Type 1 Diabetes Self-Management in the Diabetes Family Teamwork Online Intervention: Longitudinal Pilot Study. J Med Internet Res. 2019 09 13; 21(9):e15318.
    View in: PubMed
    Score: 0.092
  86. Genetic determination of islet cell autoimmunity in monozygotic twin, dizygotic twin, and non-twin siblings of patients with type 1 diabetes: prospective twin study. BMJ. 1999 Mar 13; 318(7185):698-702.
    View in: PubMed
    Score: 0.088
  87. The Effect of Age on the Progression and Severity of Type 1 Diabetes: Potential Effects on Disease Mechanisms. Curr Diab Rep. 2018 09 26; 18(11):115.
    View in: PubMed
    Score: 0.086
  88. Adjuvant Pharmacotherapies to Insulin for the Treatment of Type 1 Diabetes. Curr Diab Rep. 2018 08 17; 18(10):79.
    View in: PubMed
    Score: 0.085
  89. Ethnic differences in progression of islet autoimmunity and type 1 diabetes in relatives at risk. Diabetologia. 2018 09; 61(9):2043-2053.
    View in: PubMed
    Score: 0.084
  90. Sex- and age-dependent effects of celiac disease on growth and weight gain in children with type 1 diabetes: Analysis of the type 1 diabetes Exchange Clinic Registry. Pediatr Diabetes. 2018 06; 19(4):741-748.
    View in: PubMed
    Score: 0.081
  91. The Role of Age and Excess Body Mass Index in Progression to Type 1 Diabetes in At-Risk Adults. J Clin Endocrinol Metab. 2017 12 01; 102(12):4596-4603.
    View in: PubMed
    Score: 0.081
  92. Can Non-HLA Single Nucleotide Polymorphisms Help Stratify Risk in TrialNet Relatives at Risk for Type 1 Diabetes? J Clin Endocrinol Metab. 2017 08 01; 102(8):2873-2880.
    View in: PubMed
    Score: 0.079
  93. Excess BMI in Childhood: A Modifiable Risk Factor for Type 1 Diabetes Development? Diabetes Care. 2017 05; 40(5):698-701.
    View in: PubMed
    Score: 0.077
  94. Clinical outcomes in youth beyond the first year of type 1 diabetes: Results of the Pediatric Diabetes Consortium (PDC) type 1 diabetes new onset (NeOn) study. Pediatr Diabetes. 2017 Nov; 18(7):566-573.
    View in: PubMed
    Score: 0.075
  95. Rapid identification and expression of human TCRs in retrogenic mice. J Immunol Methods. 2016 12; 439:29-36.
    View in: PubMed
    Score: 0.074
  96. Nonaqueous, Mini-Dose Glucagon for Treatment of Mild Hypoglycemia in Adults With Type 1 Diabetes: A Dose-Seeking Study. Diabetes Care. 2016 Mar; 39(3):465-8.
    View in: PubMed
    Score: 0.071
  97. Depressive Symptoms in Youth With Type 1 or Type 2 Diabetes: Results of the Pediatric Diabetes Consortium Screening Assessment of Depression in Diabetes Study. Diabetes Care. 2015 Dec; 38(12):2341-3.
    View in: PubMed
    Score: 0.070
  98. Prediction and prevention of type 1 diabetes: update on success of prediction and struggles at prevention. Pediatr Diabetes. 2015 Nov; 16(7):465-84.
    View in: PubMed
    Score: 0.069
  99. Body mass index changes in youth in the first year after type 1 diabetes diagnosis. J Pediatr. 2015 May; 166(5):1265-1269.e1.
    View in: PubMed
    Score: 0.068
  100. Pediatric diabetes consortium T1D New Onset (NeOn) study: clinical outcomes during the first year following diagnosis. Pediatr Diabetes. 2014 Jun; 15(4):287-93.
    View in: PubMed
    Score: 0.060
  101. Race, socioeconomic status, and treatment center are associated with insulin pump therapy in youth in the first year following diagnosis of type 1 diabetes. Diabetes Technol Ther. 2013 Nov; 15(11):929-34.
    View in: PubMed
    Score: 0.060
  102. Comparison of autoantibody-positive and autoantibody-negative pediatric participants enrolled in the T1D Exchange clinic registry. J Diabetes. 2013 Jun; 5(2):216-23.
    View in: PubMed
    Score: 0.059
  103. Body mass index at the time of diagnosis of autoimmune type 1 diabetes in children. J Pediatr. 2013 Apr; 162(4):736-740.e1.
    View in: PubMed
    Score: 0.057
  104. Genetic prediction of autoimmunity: initial oligogenic prediction of anti-islet autoimmunity amongst DR3/DR4-DQ8 relatives of patients with type 1A diabetes. J Autoimmun. 2005; 25 Suppl:40-5.
    View in: PubMed
    Score: 0.035
  105. Association of non-HLA genes with type 1 diabetes autoimmunity. Diabetes. 2005 Aug; 54(8):2482-6.
    View in: PubMed
    Score: 0.034
  106. Seasonality of month of birth of children and adolescents with type 1 diabetes mellitus in homogenous and heterogeneous populations. Isr Med Assoc J. 2005 Jun; 7(6):381-4.
    View in: PubMed
    Score: 0.034
  107. Celiac disease associated with type 1 diabetes mellitus. Endocrinol Metab Clin North Am. 2004 Mar; 33(1):197-214, xi.
    View in: PubMed
    Score: 0.031
  108. Insulin autoimmunity: prediction/precipitation/prevention type 1A diabetes. Autoimmun Rev. 2002 May; 1(3):139-45.
    View in: PubMed
    Score: 0.027
  109. Reanalysis of twin studies suggests that diabetes is mainly genetic. BMJ. 2001 Oct 27; 323(7319):997-8.
    View in: PubMed
    Score: 0.027
  110. Exome sequencing in children with clinically suspected maturity-onset diabetes of the young. Pediatr Diabetes. 2021 11; 22(7):960-968.
    View in: PubMed
    Score: 0.026
  111. Self-antigen-presenting cells expressing diabetes-associated autoantigens exist in both thymus and peripheral lymphoid organs. J Clin Invest. 2001 Mar; 107(5):555-64.
    View in: PubMed
    Score: 0.025
  112. Modification of the environment is not the most efficient way to prevent type 1 diabetes. Diabetes Technol Ther. 2000; 2(4):609-16.
    View in: PubMed
    Score: 0.023
  113. Dual-parameter model for prediction of type I diabetes mellitus. Proc Assoc Am Physicians. 1998 Mar-Apr; 110(2):126-35.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.